MetaTrader
  • Mercati
  • Grafici & Idee
  • Algo
  • Notizie
  • Store
  • Broker
  • Scarica
  • Calendario Economico
  • Segnali di Trading
  • Terminale Web
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
TScan Therapeutics, Inc. Common Stock

TCRX

#3154
TScan Therapeutics, Inc. Common Stock
1.06
-3.64%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
1.06
1.06
Intervallo Annuale
0.88
2.57
Variazione giornaliera
-3.64%
Variazione Mensile
-4.50%
Variazione di 6 mesi
-43.32%
Variazione Annuale
-48.29%
Chiusura Precedente
1.10
Open
1.06
Bid
Ask
Low
1.06
High
1.06
Volume
6
  1. Mercati
  2. Mercato Azionario Statunitense
  3. Salute
  4. TCRX
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

Notizie

Investing Investing
TCRX
2026.02.26
TScan completes enrollment in trial cohort, receives FDA clearance
Zacks Zacks
RXRX TCRX
2026.02.25
Recursion Pharmaceuticals (RXRX) Reports Q4 Loss, Beats Revenue Estimates
Zacks Zacks
AGIO TCRX
2026.02.12
Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Beats Revenue Estimates
Zacks Zacks
TCRX
2026.02.11
Sutro Biopharma (STRO) Surges 11.9%: Is This an Indication of Further Gains?
Zacks Zacks
ROIV TCRX
2026.02.06
Roivant Sciences Ltd. (ROIV) Reports Q3 Loss, Misses Revenue Estimates
Seeking Alpha Seeking Alpha
INCY ABVX MDGL ALKS IMTX
2025.12.16
Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
Investing Investing
TCRX
2025.12.09
Tscan Therapeutics株式、ASHイベント後もBTIGからニュートラル評価を維持
Investing Investing
TCRX
2025.12.09
Tscan Therapeutics stock holds Neutral rating at BTIG after ASH event
Investing Investing
TCRX
2025.12.03
TScan to host KOL event discussing updated ALLOHA trial data
Investing Investing
TCRX
2025.11.13
モルガン・スタンレー、臨床試験の遅延でTscan Therapeuticsを格下げ
Investing Investing
TCRX
2025.11.13
Morgan Stanley downgrades Tscan Therapeutics stock on delayed trials
Investing Investing
TCRX
2025.11.12
【決算速報】Tscan Therapeutics、売上高は予想を上回り、利益は予想を上回る結果に

Mercati

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Grafici & Idee

  • Idee di Trading
  • Idee Educative
  • Grafici

MQL5 Community

  • Market
  • Segnali
  • Forum
  • Articoli
  • CodeBase

Notizie

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Broker

  • Tutti i Broker
  • Forex
  • Azioni
  • Metalli
MetaTrader 5
MQL5 Channels
Economic Calendar
Esclusione di Responsabilità e Informativa sui Rischi Termini di Utilizzo Contatti e richieste Legale
Copyright 2000-2026, MetaQuotes Ltd